FilingReader Intelligence
Olympus forms $458m medical device joint venture
July 28, 2025 at 07:02 AM UTC•By FilingReader AI
Olympus Corporation announced a joint venture with Revival Healthcare Capital, establishing Swan EndoSurgical to develop endoluminal robotic products.
The total investment is $458 million over six years, with Olympus contributing up to $206 million. The companies will make an initial combined contribution of $65 million.
The deal includes options for Olympus to acquire the joint venture.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
TSE:7733•Tokyo Stock Exchange
News Alerts
Get instant email alerts when Olympus Corporation publishes news
Free account required • Unsubscribe anytime